Related references
Note: Only part of the references are listed.Treatment of metastatic breast cancer: second line and beyond
H. Roche et al.
ANNALS OF ONCOLOGY (2011)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Cancer stem cells: problems for therapy?
Malcolm R. Alison et al.
JOURNAL OF PATHOLOGY (2011)
CD24 is Upregulated in Inflammatory Bowel Disease and Stimulates Cell Motility and Colony Formation
Mohamed A. H. Ahmed et al.
INFLAMMATORY BOWEL DISEASES (2010)
Molecular and clinical dissection of CD24 antibody specificity by a comprehensive comparative analysis
Glen Kristiansen et al.
LABORATORY INVESTIGATION (2010)
The clinicopathological significance of CD44(+)/CD24(-/low) and CD24(+) tumor cells in invasive micropapillary carcinoma of the breast
Weidong Li et al.
PATHOLOGY RESEARCH AND PRACTICE (2010)
Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes
Emad A. Rakha et al.
CLINICAL CANCER RESEARCH (2009)
CD24 shows early upregulation and nuclear expression but is not a prognostic marker in colorectal cancer
M. A. H. Ahmed et al.
JOURNAL OF CLINICAL PATHOLOGY (2009)
The clinicopathologic and prognostic significance of CD44+/CD24-/low and CD44-/CD24+ tumor cells in invasive breast carcinomas
Eleni Mylona et al.
HUMAN PATHOLOGY (2008)
Cancer stem cells: implications for the progression and treatment of metastatic disease
A. K. Croker et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy
Xiaoxian Li et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Biologic and clinical characteristics of breast cancer with single hormone receptor-positive phenotype
Emad A. Rakha et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
The prognostic role of a gene signature from tumorigenic breast-cancer cells.
Rui Liu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses
DM Abd El-Rehim et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
CD44 attenuates metastatic invasion during breast cancer progression
JI Lopez et al.
CANCER RESEARCH (2005)
Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties
D Ponti et al.
CANCER RESEARCH (2005)
C44 expression is associated with increased survival in node-negative invasive breast carcinoma
LK Diaz et al.
CLINICAL CANCER RESEARCH (2005)
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma
TO Nielsen et al.
CLINICAL CANCER RESEARCH (2004)
Facts and controversies in systemic treatment of metastatic breast cancer
C Bernard-Marty et al.
ONCOLOGIST (2004)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Share Paper
